Advertisement

Topics

Duke Scientific Corporation Company Profile

16:46 EDT 22nd September 2017 | BioPortfolio

Established in 1971, Duke Scientific Corporation was the first company to design and produce particle size standards for industrial laboratories. These measurement standards enable laboratories to control processes by comparing their output against accurately defined dimensions that are traceable to primary standards of measurement.

Particle dimensions from Duke Scientific are in the form of highly uniform, extremely small spherical particles, or "microspheres", with certified, traceable diameters. We provide the chain of traceability to primary standards by transferring metric dimensions from national laboratories, such as the National Institute of Standards and Technology (NIST), to the particles using methods developed in our own laboratories. They are available in a series of discrete sizes over a size range from 20 nanometers (nm) to 2000 micrometers (µm or micron).

Location

2463 Faber Place
Palo Alto
CA
94303
United States of America

Contact

Phone: 650 424 1177
Fax: 415 424 1158


News Articles [861 Associated News Articles listed on BioPortfolio]

Duke-NUS commercializes discovery for healthy brain development in babies and children

(Duke-NUS Medical School) A discovery made at Duke-NUS Medical School (Duke-NUS) has been licensed to a newly launched Singapore-based company, Babynostics Pte Ltd. Babynostics plans to use the intel...

Duke Scientists Map Genomic Atlas of your Inner Fish Gut

NewsGenetics of digestion little-changed in 420 million years.Contributed Author: 

Immunomic Therapeutics adds John H. Sampson to scientific advisory board

Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, is pleased to welcome a new oncology advisor, Duke University’s John H. Sampson, M.D., Ph.D., to the Immu...

Cash for weight loss

(Duke-NUS Medical School) A new study, published in the journal Social Science and Medicine, has shown that selling rewards programmes to participants entering a weight loss programme is a low cost st...

Biotech firm Grid signs deal with Duke U. to develop cancer antibodies

Grid Therapeutics was granted exclusive rights by Duke University to intellectual property covering antibodies for complement -More- 

Breakthrough discovery presents hope for treating fibrotic diseases which cause organ impairment

(Duke-NUS Medical School) Duke-NUS, SingHealth and NHCS researchers discovered a key driver of cardiac and renal fibrosis. Findings will be presented in the Late-Breaking session at the European Socie...

Health Highlights: June 23, 2017

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Duke of Edinburgh Hospitalized With Infection The Duke of Edinburgh was admitted to hospital for...

Health Highlights: June 22, 2017

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Duke of Edinburgh Hospitalized With Infection The Duke of Edinburgh was admitted to hospital for...

PubMed Articles [564 Associated PubMed Articles listed on BioPortfolio]

Highlights from the Ninth International Symposium of Thrombosis and Anticoagulation (ISTA IX), October 15, 2016, Salvador, Bahia, Brazil.

To discuss and share knowledge about advances in the care of patients with thrombotic disorders, the Ninth International Symposium of Thrombosis and Anticoagulation was held in Salvador, Bahia, Brazil...

Value of Duke Treadmill Score in predicting coronary artery lesion and need of revascularisation.

Exercise electrocardiography is a long-standing method for evaluation for coronary artery disese (CAD) and remains the initial test for the majority of patients who can exercise adequately with a base...

The Cutaneous Cancer of Ferdinando Orsini, 5th Duke of Gravina.

Completeness of facial self-application of sunscreen in cosmetic surgery patients.

Previous studies have demonstrated incomplete sunscreen self-application to various facial regions in cosmetic surgery patients, but there is no scientific research on the completeness of facial and p...

Mystery behind the match: an undergraduate medical education-graduate medical education collaborative approach to understanding match goals and outcomes.

Background There is a paucity of information regarding institutional targets for the number of undergraduate medical education (UME) graduates being matched to graduate medical education (GME) program...

Clinical Trials [533 Associated Clinical Trials listed on BioPortfolio]

Duke Lupus Registry

Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common...

Pain, Agitation and Delirium (PAD) Protocol in the Duke CICU

This study aims to examine the use of protocol directed sedation using the Duke PAD protocol with the current sedation medications of propofol or dexmedetomidine compared to the PAD protoc...

The Boston Scientific ENOVUS Trial

A prospective, actively controlled, consecutively enrolling, non-randomized multi center clinical evaluation of the safety and efficacy of the Boston Scientific ENOVUS AAA Endograft when u...

Boston Scientific COMET Wire Validation Study

Summary of Study Aims To assess, in a randomised fashion: 1. performance of Boston Scientific Pressure Wire versus St Jude Pressure Wire 2. performance of Boston Scientific Pr...

Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study

The goal of this study is to enroll 100 participants with Primary Progressive Multiple Sclerosis (PPMS) that have joined the MURDOCK Study Horizon 1.5 (Duke IRB Pro00011196) and the Multip...

Companies [1114 Associated Companies listed on BioPortfolio]

Duke ScientificCorporation

We are pleased to announce that on Oct. 3, Fisher Scientific International Inc. completed it's acquisition of Duke Scientific Corporation. This change means that Duke Scientific Corporation joins a pu...

Duke University Health System, Inc. and LifePoint Hospitals

Duke University Health System (DUHS) is one of the country’s leading academic health systems and is comprised of nationally-renowned Duke University Hospital, Durham Regional...

Duke Scientific Corporation

Established in 1971, Duke Scientific Corporation was the first company to design and produce particle size standards for industrial laboratories. These measurement standards enable laboratories to con...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

Duke LifePoint Healthcare

DLP Healthcare, LLC, a joint venture of Duke University Health System and LifePoint Hospitals® (NASDAQ: LPNT), was established to build a dynamic network of hospitals and other...

More Information about "Duke Scientific Corporation" on BioPortfolio

We have published hundreds of Duke Scientific Corporation news stories on BioPortfolio along with dozens of Duke Scientific Corporation Clinical Trials and PubMed Articles about Duke Scientific Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Duke Scientific Corporation Companies in our database. You can also find out about relevant Duke Scientific Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record